SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-16-004018
Filing Date
2016-01-29
Accepted
2016-01-29 16:05:39
Documents
4
Period of Report
2016-03-17
Effectiveness Date
2016-01-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ohr-def14a_031716.htm DEF 14A 664040
2 GRAPHIC img001.jpg GRAPHIC 21923
3 GRAPHIC proxycard_pg1.jpg GRAPHIC 239921
4 GRAPHIC proxycard_pg2.jpg GRAPHIC 178713
  Complete submission text file 0001387131-16-004018.txt   1272085
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 161373395
SIC: 2834 Pharmaceutical Preparations